scholarly journals Vigabatrin Therapy for Infantile Spasms in a Case of Cardiofaciocutaneous Syndrome with Cardiac Hypertrophy Developing during Adrenocorticotropic Hormone Treatment

2016 ◽  
Vol 83 (4) ◽  
pp. 167-171 ◽  
Author(s):  
Takayuki Hatori ◽  
Yohei Sugiyama ◽  
Shinichiro Yamashita ◽  
Yuka Hirakubo ◽  
Kazuhito Nonaka ◽  
...  
Keyword(s):  
Cardiac Hypertrophy ◽  
Adrenocorticotropic Hormone ◽  
Hormone Treatment ◽  
Infantile Spasms ◽  
Cardiofaciocutaneous Syndrome

Risk of infection during adrenocorticotropic hormone treatment in infants with infantile spasms

1993 ◽  
Vol 12 (11) ◽  
pp. 913-915 ◽  
Author(s):  
RAANAN SHAMIR ◽  
BEN-ZION GARTY ◽  
AVINOAM RACHMEL ◽  
SARA KIVITY ◽  
GERSHON ALPERT
Keyword(s):  
Adrenocorticotropic Hormone ◽  
Hormone Treatment ◽  
Infantile Spasms ◽  
Risk Of Infection

scholarly journals Infantile Spasms in Children With Down Syndrome: Identification and Treatment Response

2019 ◽  
Vol 6 ◽  
pp. 2333794X1882193 ◽  
Author(s):  
Dee Daniels ◽  
Kelly Knupp ◽  
Tim Benke ◽  
Kristine Wolter-Warmerdam ◽  
Maura Moran ◽  
...  
Keyword(s):  
Down Syndrome ◽  
Adrenocorticotropic Hormone ◽  
Early Recognition ◽  
Heart Defects ◽  
Hormone Treatment ◽  
Magnetic Resonance Images ◽  
Infantile Spasms ◽  
Single Institution ◽  
First Line ◽  
Children With Down Syndrome

Objectives. To evaluate infantile spasms in children with Down syndrome including assessment of efficacy of treatments, presence of treatment lag, and to identify risk factors that may predict the occurrence of infantile spasms in this population. Methods. Medical charts, electroencephalograms, and brain magnetic resonance images were evaluated in 37 children treated for infantile spasms at a single institution from 2005 to 2015. Results. Mean age at diagnosis was 9.16 months, with an average 1.38-month lag from spasms onset to start of medication. Prevalence of heart defects and pulmonary hypertension were significantly higher in those with infantile spams compared with those without. Eighty-one percent receiving adrenocorticotropic hormone as initial treatment experienced remission within 2 weeks, 94.1% had remission at 3 months compared with 18.8% at 2 weeks and 35.3% at 3 months for other first-line treatments. Type of treatment was the only predictor of good outcome. Conclusions. Results stress the importance of early recognition and adrenocorticotropic hormone treatment for this seizure disorder in children with Down syndrome.

Influence of Hormones on Sjögren’s Syndrome

2019 ◽  
Vol 24 (35) ◽  
pp. 4167-4176 ◽  
Author(s):  
Liu Yang ◽  
Wei Wei ◽  
Xi He ◽  
Yu Xie ◽  
Mohammad A. Kamal ◽  
...  
Keyword(s):  
Sjögren’S Syndrome ◽  
Adrenocorticotropic Hormone ◽  
Sjögren's Syndrome ◽  
Follicle Stimulating Hormone ◽  
Hormone Treatment ◽  
Sjogren’S Syndrome ◽  
Sjogren's Syndrome ◽  
Thyroid Stimulating Hormone ◽  
Sjögren‘S Syndrome ◽  
Stimulating Hormone

Sjögren’s syndrome (SS) is an immune system oral disorder that is characterized generally by dry mouth and eyes. In this review, SS classification, presentation and pathogenesis are briefly discussed. Moreover, the epidemiology of SS regarding sex, age and association with other complications are also presented. This review also addresses the interactions between endocrine axes and SS, and the important findings up to regarding hormone treatment of this syndrome. The main hormones discussed in this review includes Adrenocorticotropic hormone (ACTH), Follicle-stimulating hormone (FSH), Luteinizing hormone (LH), Thyroid-stimulating hormone (TSH), and prolactin.

scholarly journals Long‐term Cognitive Outcomes of a Cohort of Children with Cryptogenic Infantile Spasms Treated with High‐dose Adrenocorticotropic Hormone

Epilepsia ◽  
2004 ◽  
Vol 45 (3) ◽  
pp. 255-262 ◽  
Author(s):  
Sara Kivity ◽  
Pinchas Lerman ◽  
Raya Ariel ◽  
Yardena Danziger ◽  
Marc Mimouni ◽  
...  
Keyword(s):  
Adrenocorticotropic Hormone ◽  
Infantile Spasms ◽  
Cognitive Outcomes ◽  
High Dose

Cardiac Autonomic Dysfunction in Patients With Infantile Spasm and the Effect of Adrenocorticotropic Hormone Treatment

2015 ◽  
Vol 31 (2) ◽  
pp. 134-137 ◽  
Author(s):  
Pinar Gencpinar ◽  
Abdullah Kocabas ◽  
Özgür Duman ◽  
Nihal Olgaç Dündar ◽  
Senay Haspolat ◽  
...  
Keyword(s):  
Autonomic Dysfunction ◽  
Adrenocorticotropic Hormone ◽  
Infantile Spasm ◽  
Hormone Treatment ◽  
Cardiac Autonomic Dysfunction
Sign in / Sign up

Export Citation Format

Share Document